F-Prime Capital Partners Announces Parker Moss as New Entrepreneur-in-Residence

CAMBRIDGE, Mass.--()--F-Prime Capital Partners, a global venture capital firm focused on investments in life sciences, healthcare and technology, today announced that Parker Moss has joined the firm as entrepreneur-in-residence. Parker will be based in London and will focus on health technology investments and company-creation activities.

“We are excited to welcome Parker to the firm - he is an important addition to the F-Prime team,” said Stephen Knight, managing partner of F-Prime Capital Partners. “Parker’s experience as a senior executive in the healthcare and telecom industries, and his strong conviction and determination for transforming healthcare delivery, will be invaluable as we push further into building and investing in health technology companies. His hands-on experience on the frontline of both the hospital and the community sectors of the NHS has given him an acute sense of the barriers and opportunities for disruptive innovation in medical research, on the wards and in patients’ homes, and we look forward to working with Parker to bring some of these exciting opportunities to market.”

Prior to joining F-Prime, Parker spent five years with the National Health Service (NHS), most recently as chief technology officer of Virgin Care, the UK’s largest provider of NHS community services. He also led the digital strategy and roadmap for Great Ormond Street Hospital for Children. Prior to that, Parker held senior positions in the telecom sector, including vice president of strategy and marketing at Alcatel Lucent, head of strategy for GSMA, and was a member of the UK Prime Minister’s Strategy unit as a lead in the Digital Britain project, focusing on national telecom policy.

“F-Prime has a strong track record of creating and investing in companies at the forefront of the health technology and biotech space,” said Mr. Moss. “As biotech and infotech continue to integrate to drive better diagnostic and treatment pathways, greater efficiency and patient experiences as well as safer care in hospitals and homes, I look forward to offering my insight, experience and network toward building new companies that will improve the lives of patients around the world.”

About F-Prime Capital Partners

F-Prime Capital Partners is a global venture capital firm investing in life sciences, healthcare, and technology. Since 1969, F-Prime has worked closely with entrepreneurs and academics to create innovative solutions to some of the world's most significant challenges in healthcare and technology. For more information, please visit fprimecapital.com.

Contacts

F-Prime Capital Partners
Davina Magargal, 617-397-0024
dmagargal@fprimecapital.com

Contacts

F-Prime Capital Partners
Davina Magargal, 617-397-0024
dmagargal@fprimecapital.com